- This event has passed.
Presenter(s): Hillary S. Connery, MD, PhD, Clinical Director Division of Alcohol, Drugs, and Addiction at McLean Hospital Department of Psychiatry, Harvard Medical School
Note: Once the live event has passed, please allow two weeks for the recording and slide presentations to be posted.
This webinar is designed for physicians, psychiatrists, nurses, and interprofessional teams. The live webinar is accredited for physicians.
Credit Designations Available: a maximum of 1.0 AMA PRA Category 1 Credit™
Webinar Description: This webinar will review the complex relationships between substance misuse and suicide, with a focus on opioid use disorder (OUD) as a category associated with significant elevation of suicide risk and premature mortality. Methodological challenges in detecting drug poisoning suicides will be reviewed along with emerging clinical data that suggest treatment-seeking OUD patients who have survived non-fatal opioid overdose report desire and intention to die prior to overdose along a continuum of severity, suggesting the utility of suicide screening and prevention integrated into routine care of patients with OUD.
- Describe how suicide risks are elevated for both prescription and illicit opioid misuse.
- Define psychological and social risk factors commonly experienced by OUD patients.
- Discuss how opioids have the highest lethality among suicide poisonings and apply personalized suicide prevention planning approaches to enhance care and reduce premature death.
Physician Continuing Medical Education (CME) Credit
The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Psychiatric Association designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.